| Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD (NCT01728220) | Bellerophon Pulse Technologies | 2012-12-01 |
| A Study of the Safety, Pharmacokinetic Drug Interaction and Efficacy of ETC-1002 and Atorvastatin in Subjects With Hypercholesterolemia (NCT01779453) | Esperion Therapeutics, Inc. | 2012-12-01 |
| Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD). (NCT01624636) | Novartis Pharmaceuticals | 2012-12-01 |
| Safety Study of ADV-specific T-cells in Paediatric Patients Post Allo-HSCT (NCT01822093) | Cell Medica Ltd | 2012-12-01 |
| ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA (NCT01730612) | Nantes University Hospital | 2012-12-01 |
| Safety and Efficacy of UC-MSC in Patients With Acute Severe Graft-versus-host Disease (NCT01754454) | Affiliated Hospital to Academy of Military Medical Sciences | 2012-12-01 |
| An Open,Single-centre Pilot Study of Efficacy and Safety of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) (NCT01814020) | Moberg Pharma AB | 2012-12-01 |
| Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol (NCT04032652) | Endeavor Health | 2012-12-01 |
| Treatment of Neuroendocrine Tumors (NETs) With Combination of Everolimus and Radiolabeled Somatostatin Analogue (NCT03629847) | King Faisal Specialist Hospital & Research Center | 2012-12-01 |
| Randomized Clinical Trial of Intravenous Infusion Umbilical Cord Mesenchymal Stem Cells on Cardiopathy (NCT01739777) | Universidad de los Andes, Chile | 2012-12-01 |
| The Short-term Effects of Simvastatin on the Vision of Males Affected by Choroideremia (NCT01654562) | University of Alberta | 2012-12-01 |
| Decitabine Followed by Donor Lymphocyte Infusion for Patients With Relapsed Acute Myeloblastic Leukemia(AML) After Allogeneic Stem Cell Transplantation (NCT01758367) | Chinese PLA General Hospital | 2012-12-01 |
| Proton or Photon RT for Retroperitoneal Sarcomas (NCT01659203) | Massachusetts General Hospital | 2012-12-01 |
| A Phase 2 Clinical Study of KHK4827 (NCT01748539) | Kyowa Kirin Co., Ltd. | 2012-12-01 |
| Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne (NCT01657110) | The University of Western Australia | 2012-12-01 |
| Phase II Study of Cabazitaxel in Refractory Metastatic Gastric or Gastroesophageal Adenocarcinoma (NCT01757171) | Weill Medical College of Cornell University | 2012-12-01 |
| Efficacy and Safety Study of Afatinib to Treat Lung Cancer Patients (NCT01415011) | University College, London | 2012-12-01 |
| Intratumoral Administration of L19IL2/L19TNF (NCT02076633) | Philogen S.p.A. | 2012-12-01 |
| Applied The Platelet Rich Fibrin in Chronic Periodontitis (NCT02594605) | Ataturk University | 2012-12-01 |
| Iron Treatment of Sleep Disorders in Children With Autism Spectrum Disorder (NCT01745497) | University of Colorado, Denver | 2012-12-01 |
| Use of a Calcium Channel Blocker to Prevent Premature Luteinizing Hormone Surges in Infertility Patients (NCT01551368) | Mount Sinai Hospital, Canada | 2012-12-01 |
| Safety and Efficacy of Oncoxin Plus Surafineb in Hepatocellular Carcinoma (NCT01747642) | Clinical Research Organization, Dhaka, Bangladesh | 2012-12-01 |
| A Phase II Study to Evaluate the Efficacy and Safety of TLC388 in Advanced/Metastatic RCC Patients (NCT01831973) | Taiwan Liposome Company | 2012-11-30 |
| 18F-CP18 Imaging Studies for Cancer Treatment With Birinapant (NCT01766622) | National Institutes of Health Clinical Center (CC) | 2012-11-30 |
| An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738) (NCT01739348) | Merck Sharp & Dohme LLC | 2012-11-30 |
| Nivolumab and Ipilimumab in Treating Patients With Metastatic Uveal Melanoma (NCT01585194) | M.D. Anderson Cancer Center | 2012-11-29 |
| Study of Sotatercept for the Treatment of Anemia in low-or Intermediate-1 Risk Myelodysplastic Syndromes (MDS) or Non-proliferative Chronic Myelomonocytic Leukemia (CMML) (NCT01736683) | Merck Sharp & Dohme LLC | 2012-11-28 |
| A Study Evaluating the Efficacy and Safety of ARTISS Human Fibrin Sealant as Used in External Rhinoplasty (NCT01684020) | DeNova Research | 2012-11-28 |
| Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Previously Treated Stage IV Non-small Cell Lung Cancer (NCT01725165) | M.D. Anderson Cancer Center | 2012-11-28 |
| Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ASB17061 Capsules in Adult Subjects With Atopic Dermatitis (NCT01756898) | Daiichi Sankyo | 2012-11-28 |
| A Phase Ib/II Study of the Combination of BYL719 Plus AMG 479 in Adult Patients With Selected Solid Tumors (NCT01708161) | Novartis Pharmaceuticals | 2012-11-27 |
| LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib (NCT01685060) | Novartis Pharmaceuticals | 2012-11-26 |
| Evaluate the Efficacy and Safety of Pasireotide LAR (Long Acting Release) on the Treatment of Patients With Clinically Non-Functioning Pituitary Adenoma. (NCT01283542) | Novartis Pharmaceuticals | 2012-11-26 |
| Study of LGX818 and Cetuximab or LGX818, BYL719, and Cetuximab in BRAF Mutant Metastatic Colorectal Cancer (NCT01719380) | Pfizer | 2012-11-23 |
| An Open-label, Randomized Phase II Study to Evaluate the Efficacy of AUY922 vs Pemetrexed or Docetaxel in NSCLC Patients With EGFR Mutations (NCT01646125) | Novartis Pharmaceuticals | 2012-11-23 |
| Allogeneic Stem Cell Transplant for CLL (NCT01629511) | M.D. Anderson Cancer Center | 2012-11-21 |
| Open Label Study of the Efficacy and Safety of MBL-HCV1 in Combination With Oral Direct-Acting Antivirals in Patients Undergoing Liver Transplantation for Hepatitis C (NCT01532908) | MassBiologics | 2012-11-21 |
| Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer (NCT01684397) | Roswell Park Cancer Institute | 2012-11-21 |
| Study of Pembrolizumab (MK-3475) Versus Chemotherapy in Participants With Advanced Melanoma (MK-3475-002/P08719/KEYNOTE-002) (NCT01704287) | Merck Sharp & Dohme LLC | 2012-11-20 |
| Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma (NCT01965834) | University of Miami | 2012-11-19 |
| Open-label, Uncontrolled Phase II Trial of Intravenous PI3K Inhibitor BAY80-6946 in Patients With Relapsed, Indolent or Aggressive Non-Hodgkin's Lymphomas (NCT01660451) | Bayer | 2012-11-19 |
| Novel Therapeutics in Posttraumatic Stress Disorder (PTSD): A Randomized Clinical Trial of Mifepristone (NCT01739335) | VA Office of Research and Development | 2012-11-19 |
| Study of Nivolumab (BMS-936558) in Patients With Advanced or Metastatic Squamous Cell Nonsmall-cell Lung Cancer Who Have Received At Least 2 Prior Systemic Regimens (NCT01721759) | Bristol-Myers Squibb | 2012-11-16 |
| A Study of the Safety, Tolerability, and Antiretroviral Activity of Raltegravir (MK-0518) in Combination With Other Antiretroviral Therapies in Russian Children and Adolescents Infected With Human Immunodeficiency Virus (HIV-1) (MK-0518-248) (NCT01717287) | Merck Sharp & Dohme LLC | 2012-11-16 |
| Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis (NCT01694485) | Amgen | 2012-11-16 |
| Lentiviral (LV) Gene Therapy for Adenosine Deaminase (ADA) Deficiency (NCT01380990) | Great Ormond Street Hospital for Children NHS Foundation Trust | 2012-11-15 |
| Myrcludex B vs Entecavir in Patients With HBeAg Negative Chronic Hepatitis B (NCT02881008) | Hepatera Ltd. | 2012-11-14 |
| Revatio Portal-Pulmonary Arterial Hypertension Trial (NCT01517854) | University Health Network, Toronto | 2012-11-14 |
| Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer (NCT01652196) | John Hays | 2012-11-14 |
| Ofatumumab as Primary Therapy of Chronic Graft Versus Host Disease (NCT01680965) | H. Lee Moffitt Cancer Center and Research Institute | 2012-11-14 |
| Allogeneic Heart Stem Cells to Achieve Myocardial Regeneration (NCT01458405) | Capricor Inc. | 2012-11-13 |
| A Phase Ib/II Study of BYL719 and Cetuximab in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (NCT01602315) | Novartis Pharmaceuticals | 2012-11-12 |
| A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma (NCT01724177) | Celgene | 2012-11-12 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older (NCT01732627) | Sanofi Pasteur, a Sanofi Company | 2012-11-12 |
| Phase 2 Study of Ipilimumab in Children and Adolescents (12 to < 18 Years) With Previously Treated or Untreated, Unresectable Stage III or Stage lV Malignant Melanoma (NCT01696045) | Bristol-Myers Squibb | 2012-11-12 |
| Community Intervention to Prevent Nipah Spillover (NCT01811784) | International Centre for Diarrhoeal Disease Research, Bangladesh | 2012-11-10 |
| Dabrafenib With or Without Trametinib in Treating Patients With Advanced Differentiated Thyroid Cancer (NCT01723202) | Bhavana Konda | 2012-11-07 |
| Vemurafenib Neoadjuvant Trial in Locally Advanced Thyroid Cancer (NCT01709292) | M.D. Anderson Cancer Center | 2012-11-07 |
| Decitabine Versus Azacitidine in Myelodysplastic Syndrome Patients With Low and Intermediate-1 Risk (NCT01720225) | M.D. Anderson Cancer Center | 2012-11-06 |
| Dose-related Effects of Vitamin D3 on Immune Responses in Patients With Clinically Isolated Syndrome (NCT01728922) | University College Dublin | 2012-11-06 |
| Cabozantinib or Paclitaxel in Treating Patients With Persistent or Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT01716715) | National Cancer Institute (NCI) | 2012-11-06 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma (NCT01646762) | Mayo Clinic | 2012-11-05 |
| Dalantercept in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer (NCT01720173) | Gynecologic Oncology Group | 2012-11-05 |
| Safety and Efficacy of Allogeneic Cells for the Treatment of Intermittent Claudication(IC) (NCT01679990) | Pluristem Ltd. | 2012-11-05 |
| A Study Of PF-00547659 In Patients With Moderate To Severe Ulcerative Colitis (NCT01620255) | Shire | 2012-11-02 |
| Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies (NCT01697527) | Jonsson Comprehensive Cancer Center | 2012-11-02 |
| Multicenter Phase II of CD26 Using Sitagliptin for Engraftment After UBC Transplant (NCT01720264) | Sherif S. Farag | 2012-11-02 |
| Efficacy Mechanism of N-acetylcysteine in Patients With Posttraumatic Stress Disorder (NCT01664260) | Ewha Womans University | 2012-11-01 |
| Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli (NCT02537847) | Mahidol University | 2012-11-01 |
| Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients (NCT01718587) | General Hospital of Chinese Armed Police Forces | 2012-11-01 |
| Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml). (NCT01734265) | Laboratorios Leti, S.L. | 2012-11-01 |
| A Pilot Study of Metformin Therapy in Patients With Relapsed Chronic Lymphocytic Leukemia (CLL) and Untreated CLL (NCT01750567) | University of Michigan Rogel Cancer Center | 2012-11-01 |
| The VO2 Increase With Testosterone Addition - Heart Failure (VITA-HF) Trial (NCT01469988) | University of Alberta | 2012-11-01 |
| A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy (NCT01643408) | Jazz Pharmaceuticals | 2012-11-01 |
| A Study to Evaluate the Efficacy and Safety of VB-201 in Patients With Psoriasis (NCT01837420) | Vascular Biogenics Ltd. operating as VBL Therapeutics | 2012-11-01 |
| Mechanistic Study of Indigo Naturalis in Treating Psoriasis (NCT02088281) | Chang Gung Memorial Hospital | 2012-11-01 |
| TKI 258 in Von Hippel-Lindau Syndrome (VHL) (NCT01266070) | M.D. Anderson Cancer Center | 2012-11-01 |
| Safety, Tolerability, Pharmacokinetics of EVP-0962 and Effects of EVP-0962 on Cerebral Spinal Fluid Amyloid Concentrations in Healthy Subjects and in Subjects With Mild Cognitive Impairment or Early Alzheimer's Disease (NCT01661673) | FORUM Pharmaceuticals Inc | 2012-11-01 |
| Amyloid Accumulation After Mild Traumatic Brain Injury (NCT01871610) | Chang Gung Memorial Hospital | 2012-11-01 |
| Partner-Assisted Interpersonal Psychotherapy or Antidepressant Medication for Antenatal Depression (NCT01732055) | University of North Carolina, Chapel Hill | 2012-11-01 |
| Intra-arterial Hepatic Bevacizumab and Systemic Chemotherapy (NCT01677884) | Gustave Roussy, Cancer Campus, Grand Paris | 2012-11-01 |
| Pilot Study of Zoledronic Acid in Combination With First-line Chemotherapy in Aged Patients With Lung Cancer (NCT01737216) | Hebei Tumor Hospital | 2012-11-01 |
| Pelvic External Combined With 252-Cf Neutron Intracavitary Radiotherapy With or Without Platinum in Treating Advanced Cervical Cancer (NCT02835404) | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | 2012-11-01 |
| Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV) (NCT01756482) | Gilead Sciences | 2012-11-01 |
| Safety and Efficacy of SA09012 in Asthma (NCT01740986) | SamA Pharmaceutical Co., Ltd | 2012-11-01 |
| The Safety and Efficacy of a Peanut Immunotherapy Dissolving Film for Peanut Allergy (NCT01897077) | Johns Hopkins University | 2012-11-01 |
| NOLAN: Naproxen or Loratadine and Neulasta (NCT01712009) | Amgen | 2012-11-01 |
| An 8-week, Open-label, Uncontrolled Study of Tamsulosin 0.4mg in Men With Bothersome Urinary Symptoms (NCT01726270) | Boehringer Ingelheim | 2012-11-01 |
| A Clinical Trial to Study the Effects GRC 17536 in Patients With Painful Diabetic Peripheral Neuropathy (Painful Extremities Due to Peripheral Nerve Damage in Diabetic Patients). (NCT01726413) | Glenmark Pharmaceuticals Ltd. India | 2012-11-01 |
| Open-label Investigation of the Safety and Efficacy of DIABECELL in Patients With Type 1 Diabetes Mellitus (NCT01736228) | Living Cell Technologies | 2012-11-01 |
| Safety and Efficacy of Vanoxerine for Conversion of Atrial Fibrillation or Flutter to Normal Sinus Rhythm (NCT01691313) | Laguna Pharmaceuticals, Inc. | 2012-11-01 |
| High Dose Chemo With Stem Cell Transplant as Treatment for Multiple Sclerosis That Failed Prior Treatment (NCT01679041) | Seah Lim M.D. | 2012-11-01 |
| Dose Finding Study of Albuterol Sulfate in Patients With Intermittent or Persistent Mild Asthma (NCT01252758) | Acerus Pharmaceuticals Corporation | 2012-11-01 |
| 3-D Imaging Assessment of Scar Formation and Would Healing in Fat Grafted vs Non-Fat Grafted Facial Reconstruction Wound Sites (NCT01750424) | Yale University | 2012-11-01 |
| Cromoglicate in Psoriasis (NCT01722812) | LEO Pharma | 2012-11-01 |
| Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer (NCT01741116) | Korean Cancer Study Group | 2012-11-01 |
| A Comparison of Ketamine Infusion Versus Placebo in Opioid Tolerant and Opioid Naive Patients After Spinal Fusion (NCT03274453) | NYU Langone Health | 2012-11-01 |
| Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy (NCT01809444) | Sun Yat-sen University | 2012-11-01 |
| Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula (NCT01863914) | National Cheng-Kung University Hospital | 2012-11-01 |
| PRO 140 for Human Immunodeficiency Virus (NCT02438345) | Drexel University | 2012-11-01 |